°ÄÃÅÁùºÏ²Ê¿ª½±¼Ç¼

This course has been updated to reflect the recent changes in the pharmaceutical stability testing world.

The new course content will provide a comprehensive update on current trends which offer substantial potential savings in time and resources in a traditionally costly testing area. It will include opportunities for review of specific participant problems

The course will cover:
Recent regulatory changes affecting stability including:
• The implications of implementation of ICH Q7, Q8, Q9, Q10 and Q11 for stability testing
• Changes to European GMP guidance with impact on stability testing including Annexe updates affecting product development, outsourcing and application of Quality Risk Management (QRM)
• Product Quality Reviews and the interpretation of stability data.

Recent scientific developments with implications for stability, with a particular focus on cost reduction, shortening of development timelines, and improvements on existing interpretation systems.
• ASAP - using short term high stress testing to get accurate predictions of shelf life with a high degree of confidence – Freethink Technologies' ASAPprime®
• Low level impurities and their impact on product stability
• Manipulation of tablet internal pH to improve product stability

The course is designed for people working in:
• Analytical and Product Development
• Analytical Chemistry
• Stability Testing
• Formulation Development
• Regulatory Affairs
• Pharmaceutical & Biopharmaceutical Production
• Quality Control and Quality Assurance
• Technical Operations

Window Conference Venue

Window Conference Venue, 14 Windsor Street, Islington, London, N1 8QG, United Kingdom